Regulatory Incentives and Orphan Drug Policies Imp..

created a new article

6 w

Regulatory Incentives and Orphan Drug Policies Impacting the Market | #congenital Hyperinsulinism

Regulatory Incentives and Orphan Drug Policies Impacting the Market

Regulatory Incentives and Orphan Drug Policies Impacting the Market

Congenital hyperinsulinism (CHI) is a rare genetic condition characterized by inappropriate and excessive insulin secretion, leading to persistent hypoglycemia, particularly in newborns and infants.

Like

Comment

Share